BPC-157 / TB-500
Both appear in research on tissue responses, but they describe different compounds. This comparison separates observations about BPC-157 from those about thymosin beta-4 and the fragment called TB-500.
The points below summarize the two editorial profiles. Studies, formulations and doses are not interchangeable; open each profile for detail and sources.
BPC-157
TB-500
Tissue protection and repair
Tissue recovery
Preclinical research examines cell migration, blood-vessel formation and signalling associated with repair.
TB-500 is presented as a synthetic fragment related to thymosin beta-4 and processes of cell migration.
It is best known for research involving tendons, muscle, wounds and the gastrointestinal lining.
It is of interest to readers exploring the biology of tissue repair and responses to injury.
Most findings come from animal models, with repair signals reported in several tissues. Human clinical evidence is much more limited.
Discussed mechanisms include cell migration, angiogenesis, and tissue repair.
Laboratory findings do not establish efficacy or a therapeutic indication in people.
Evidence on full-length thymosin beta-4 is not automatically evidence for every product called TB-500.
This comparison does not suggest which compound to use and is not medical advice. Information refers to the settings described in the respective profiles.